Dr. Danielle Bourque is Metabolic Physician in the Division of Metabolics and Newborn Screening at CHEO in Ottawa. She is also an Assistant Professor of Pediatrics at the University of Ottawa. Following a 5 year residency in Medical Genetics at the University of Ottawa, Dr. Bourque completed a Fellowship in Clinical Biochemical Genetics at the Hospital for Sick Children in Toronto in 2020. Dr. Bourque’s research interests include natural history studies of rare conditions and novel therapeutics for inherited metabolic diseases. Dr. Bourque is an active teacher with postgraduate medical education and is involved with provincial and national organizations advocating for care of patients with rare diseases.

Dr. Marisa Chard – I obtained an MD from Memorial University in 2011. I then completed a pediatric residency at Memorial University/Janeway Children’s Hospital in 2015 followed by a CCMG fellowship in clinical biochemical genetics at University of Calgary/Alberta Children’s Hospital in 2018. I worked as a staff physician providing IMD care in Saskatoon, SK from 2018-2020. From 2020 to present I am a staff physician providing IMD care at NL Health Services in St. John’s, NL and I am an Assistant Professor in Pediatrics at Memorial University’s Faculty of Medicine.

Dr. Aneal Khan – The primary goal of my research is to investigate novel methods of treatment of genetic diseases and provide rapid genomic diagnostic testing. As a pediatrician, medical geneticist and metabolic diseases specialist, my clinical research has primarily included subjects with rare metabolic and genetic diseases. Past experience has included gene therapy for Fabry disease, Gaucher disease, OTC deficiency, ASOT therapy for Angelman syndrome, and mitochondrial disease management. I cofounded the first in Alberta clinically accredited whole exome / genome sequencing laboratory (Discovery DNA). I am currently the medical director of M.A.G.I.C. Clinic (Metabolics and Genetics in Canada) which is a community-based clinic in Calgary.

Dr Laberge is a Medical Geneticist and Head of the Division of Medical Genetics at CHU Ste-Justine, and Professor in the Department of Pediatrics and in the Department of Social and Preventive Medicine at the School of Public Health at the Université de Montréal. She completed her MD and residency in Medical Genetics at Université de Montréal. She has an MPH in Public Health Genetics and a PhD in Public Health Genetics, both at the University of Washington. Dr Laberge is currently Chair of the Quebec Advisory Committee on Newborn Screening, of the Quebec Molecular Diagnosis Network Incidental Findings Working Group and of the Quebec Central Ethics Committee on Medically Assisted Reproduction. Her current research includes assessments of carrier screening programs in Quebec and studies on the clinical utility, patient/parent perspectives and clinician perspectives of genomic sequencing in pediatric care.